MaSTherCell

Masthercell S.A. is a Contract Manufacturing Company (CMO) located in the booming biotech Park of Gosselies, Belgium; the company wants to focus exclusively on the cell therapy products and technologies, dedicating all its efforts, expertise, equipments and bioanalytics to this specific emerging field.

Thanks to its excellent biologistics and favorable regulatory environment for stem cells research and clinical trials, Belgium is indeed an excellent place to develop and produce cell therapy products, (Tigenix, Bone therapeutics, Cardio3 Biosciences and Promethera being all close to the Masthercell location).

Masthercell is rich of a well-seasoned management team, providing for years of expertise in R&D and leadership (Jean-Paul Prieels), manufacturing (Patrick Stragier), Business development (Didier Argentin) and finances (François Lesage).

Private investors include the Management, the Brussels University, Ms Bultot and Castillo, Artelis co-founders, while Sambrinvest and Sofipole act as institutional investors.

The facilities feature 650 sqm, including 200 sqm GMP facilities, mainly production aseptic rooms.

Milestones

2Q/2012: R&D labs available at the Brussels University.
4Q/2012: operational GMP facilities